Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$10.7 - $17.48 $15,129 - $24,716
1,414 New
1,414 $24,000
Q1 2022

May 12, 2022

SELL
$6.96 - $12.15 $55,728 - $97,285
-8,007 Closed
0 $0
Q4 2021

Jun 21, 2023

BUY
$11.72 - $19.66 $93,842 - $157,417
8,007 New
8,007 $95,000
Q3 2021

Jun 21, 2023

BUY
$16.73 - $20.9 $133,957 - $167,346
8,007 New
8,007 $141,000
Q2 2021

Jun 21, 2023

BUY
$17.23 - $22.02 $137,960 - $176,314
8,007 New
8,007 $164,000
Q2 2021

Mar 30, 2023

BUY
$17.23 - $22.02 $137,960 - $176,314
8,007 New
8,007 $164,000
Q2 2021

Aug 16, 2021

BUY
$17.23 - $22.02 $137,960 - $176,314
8,007 New
8,007 $164,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $217M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.